A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
Clinical trial NCT04299464 · COMPLETED
Trial details
- NCT number
- NCT04299464
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2024-05-15
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.